CLINICAL_TRIALS
trial_result
· 2019-02-06
Clinical Trial Update: Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH) [Phase 2]
Summary
Phase 2 trial comparing Selonsertib plus prednisolone versus prednisolone alone in severe alcoholic hepatitis has completed, with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Alcoholic Hepatitis (AH) | Phase 2 | Status: COMPLETED | Results posted: 2019-02-06